Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration

BACKGROUND AND OBJECTIVES: Inhibition of Abelson (Abl) tyrosine kinase as a therapeutic target has been gaining attention in neurodegeneration. Post-mortem Alzheimer’s and Parkinson’s disease brains show that the levels of several other tyrosine kinases, including Discoidin Domain Receptors (DDR1/2)...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Drugs R D
Glavni autori: Fowler, Alan J., Hebron, Michaeline, Missner, Alexander A., Wang, Ruchong, Gao, Xiaokong, Kurd-Misto, Bahjat T., Liu, Xiaoguang, Moussa, Charbel E.-H.
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2019
Teme:
Original Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544596/
https://ncbi.nlm.nih.gov/pubmed/30919310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-019-0266-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items